Advertisement

Topics

MRI/PET scans reveal racial disparities in Alzheimer’s disease biomarkers

14:31 EST 8 Jan 2019 | Cardiovascular Business

The findings suggest the evaluation of molecular biomarkers for Alzheimer’s disease should be adjusted for race, as African American patients were found to have lower levels of tau—a key biomarker used to identify the disease, according to research published online Jan. 7 in JAMA Neurology.

Original Article: MRI/PET scans reveal racial disparities in Alzheimer’s disease biomarkers

NEXT ARTICLE

More From BioPortfolio on "MRI/PET scans reveal racial disparities in Alzheimer’s disease biomarkers"

Advertisement
Quick Search
Advertisement
Advertisement